GMO argues that deep value stocks—those trading at steep discounts to fundamental value—represent a historically rare opportunity. GMO outlines why active, research-driven approaches to value investing may be better suited than traditional passive or index-based strategies.
A Historic Opportunity in Deep Value Stocks
GMO
Catherine LeGraw
Research
3 Pages
Key Takeaways
Extremely cheap valuations: Deep value stocks in the U.S. and globally are near bottom-decile valuations relative to history
Better metrics matter: GMO’s restated financials and tailored projections help avoid value traps and find truly mispriced assets
Beyond U.S. growth bias: International value exposure may offer useful diversification away from the U.S.-centric tech-heavy benchmarks